1. 24 HIGHER BODY MASS INDEX IS ASSOCIATED WITH INCREASED RISK OF TREATMENT FAILURE AND SURGERY IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS. (18th January 2018) Authors: Kurnool, Soumya; Nguyen, Nghia H; Proudfoot, James; Dulai, Parambir S; Boland, Brigid S; Casteele, Niels Vande; Evans, Elisabeth; Grunvald, Eduardo L; Zarrinpar, Amir; Sandborn, William J; Singh, Siddharth Journal: Inflammatory bowel diseases Issue: Volume 24(2018)Supplement 1 Page Start: S72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions. Issue 10 (18th September 2020) Authors: Porter, Amy C; Aubrecht, Jiri; Birch, Chandler; Braun, Jonathan; Cuff, Carolyn; Dasgupta, Suryasarathi; Gale, Jeremy D; Hinton, Robert; Hoffmann, Steven C; Honig, Gerard; Linggi, Bryan; Schito, Marco; Casteele, Niels Vande; Sauer, John-Michael Journal: Inflammatory bowel diseases Issue: Volume 26:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions. Issue 10 (25th August 2020) Authors: Porter, Amy C; Aubrecht, Jiri; Birch, Chandler; Braun, Jonathan; Cuff, Carolyn; Dasgupta, Suryasarathi; Gale, Jeremy D; Hinton, Robert; Hoffmann, Steven C; Honig, Gerard; Linggi, Bryan; Schito, Marco; Casteele, Niels Vande; Sauer, John-Michael Journal: Inflammatory bowel diseases Issue: Volume 26:Issue 10(2020) Page Start: 1498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study. Issue 11 (November 2017) Authors: Westera, Liset; van Viegen, Tanja; Jeyarajah, Jenny; Azad, Azar; Bilsborough, Janine; van den Brink, Gijs R; Cremer, Jonathan; Danese, Silvio; D'Haens, Geert; Eckmann, Lars; Faubion, William; Filice, Melissa; Korf, Hannelie; McGovern, Dermot; Panes, Julian; Salas, Azucena; Sandborn, William J; Si... Journal: Clinical and translational gastroenterology Issue: Volume 8:Issue 11(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Covariates Influencing the Exposure‐Response Relationship for Certolizumab Pegol During the Induction and Maintenances Phases in Patients with Crohn's Disease: 572. (October 2016) Authors: Casteele, Niels Vande; Feagan, Brian; Vermeire, Séverine; Yassine, Mohamed; Hasan, Iram; Coarse, Jason; Kosutic, Gordana; Sandborn, William J. Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn's Disease Biopsies. Issue 7 (20th August 2022) Authors: Lefèvre, Pavine; Guizzetti, Leonardo; McKee, Trevor D.; Zou, Guangyong; van Viegen, Tanja; McFarlane, Stefanie C.; Shackelton, Lisa; Feagan, Brian G.; Jairath, Vipul; Pai, Rish K.; Casteele, Niels Vande Journal: Applied immunohistochemistry & molecular morphology Issue: Volume 30:Issue 7(2022) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-103 Refinement of Population Pharmacokinetic Model of Certolizumab Pegol in Crohn's Disease Patients to Account for Time Varying Nature of Covariates. (March 2016) Authors: Casteele, Niels Vande; Mould, Diane; Kosutic, Gordana; Spearman, Marshall; Feagan, Brian; Sandborn, William Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-103 Refinement of Population Pharmacokinetic Model of Certolizumab Pegol in Crohn's Disease Patients to Account for Time Varying Nature of Covariates. (March 2016) Authors: Casteele, Niels Vande; Mould, Diane; Kosutic, Gordana; Spearman, Marshall; Feagan, Brian; Sandborn, William Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P154 PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS. (18th January 2018) Authors: Singh, Siddharth; George, John; Boland, Brigid S; Casteele, Niels Vande; Sandborn, William J Journal: Inflammatory bowel diseases Issue: Volume 24(2018)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Patients with High Anti‐drug Antibody Titers Require a Higher Cumulative Infliximab Dose to Achieve Target Drug Concentrations: A Post‐hoc Analysis of the TAXIT Trial: 707. (October 2016) Authors: Casteele, Niels Vande; Van Stappen, Thomas; Van Assche, Gert; Ferrante, Marc; Vermeire, Séverine; Gils, Ann Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗